CurvaFix, Inc.
United States
- Bellevue, Washington
- 17/07/2023
- Series C
- $39,000,000
CurvaFix is developing implantable products to improve fracture repair in curved bones. The company is focusing on Fragility Fractures of the Pelvis (FFP) and high-impact pelvic fractures. The CurvaFix® IM Implant is the only intramedullary device capable of following the natural bone shape and filling the space within curved bones such as the pelvis.
- Industry Medical Equipment Manufacturing
- Website https://curvafix.com/
- LinkedIn https://www.linkedin.com/company/curvafix-llc/
Related People
Steve DimmerFounder
United States -
Bellevue, Washington
30 years building medical technology companies. Deep experience leading development and commercialization of novel, disruptive health care solutions spanning diagnostic & therapeutic medical devices and drug delivery. Built world class teams in areas of orthopedics, pulmonology, oncology, diagnostics, and general surgery. Raised over $80 million from angels, VCs, family offices, and strategics. Inventor on over 100 U.S patents.
Ethermed | $8,500,000 | (Apr 17, 2026)
Joyful Health | $17,000,000 | (Apr 17, 2026)
Worki.ai | $2,750,000 | (Apr 17, 2026)
Balerion AI | $6,000,000 | (Apr 17, 2026)
Beeline Medicines | $300,000,000 | (Apr 17, 2026)
Expo | $45,000,000 | (Apr 17, 2026)
Sepion Technologies | $10,000,000 | (Apr 17, 2026)
Lua AI (YC F25) | $5,800,000 | (Apr 17, 2026)
Nas.com | $27,000,000 | (Apr 17, 2026)
Resolv | $1,000,000 | (Apr 17, 2026)
Solidroad | $25,000,000 | (Apr 17, 2026)
Parasail | $32,000,000 | (Apr 16, 2026)